The overexpression of 14‐3‐3ζ and Hsp27 promotes non–small cell lung cancer progression

Abstract

The current data suggest that the combined expression of 14-3-3ζ and Hsp27 may be a biomarker for predicting survival in patients with NSCLC, and this combination may have potential as a therapeutic target for NSCLC.